Journal Information
Vol. 41. Issue 1.
Pages 2-4 (February 2005)
Share
Share
Download PDF
More article options
Vol. 41. Issue 1.
Pages 2-4 (February 2005)
Editorial
Full text access
¿Cuánto falta para la vacuna antinicotina?
Visits
8246
J.I. de Granda Orive
Corresponding author
igo01m@saludalia.com

Correspondencia: Dr. J.I. de Granda Orive. Cavanilles, 43, 7.° E. 28007 Madrid. España.
Servicio de Neumología. Hospital General Básico de la Defensa de Valencia. Valencia. España
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
K.F. Bonese, B.H. Wainer, F.W. Fitch, R.M. Rothberg, C.R. Shuster.
Changes in heroin self administration by rhesus monkey after morphine immunization.
Nature, 252 (1974), pp. 708-710
[2.]
A. Killian, K. Bonese, R.M. Rothberg, B.H. Wainer, C.R. Schuster.
Effects of passive immunization against morphine on heroin administration.
Pharmacol Biochem Behav, 9 (1978), pp. 347-352
[3.]
J.I. Granda Orive, S. Solano Reina, C.A. Jiménez Ruiz, T. Gutiérrez Jiménez, J.M. Martínez Albiach.
La vacuna antinicotina.
Otoneumoalergia Práctica, 12 (2003), pp. 20-24
[4.]
Granda Orive JI. El tabaquismo como enfermedad adictiva crónica. En: Jiménez Ruiz CA, Fagerström K, editores. Tratado de tabaquismo. Grupo Aula Médica. En prensa. 2004.
[5.]
M.R.A. Carrera, J.A. Ashley, L.H. Parsons, P. Wirsching, G.F. Koob, K.D. Janda.
Suppression of psychoactive effects of cocaine by active inmunization.
Nature, 378 (1995), pp. 727-730
[6.]
B.S. Fox, K.M. Kantak, M.A. Edwards, K.M. Black, B.K. Böllinger, A.J. Botka, et al.
Efficacy of a therapeutic cocaine vaccine in rodent models.
Nature Medicine, 2 (1996), pp. 1129-1132
[7.]
D.A. Keyler, Y. Hieda, J.S. Peter, P.R. Pentel.
Altered disposition of repeated nicotine doses in rats immunized against nicotine.
Nicotine Tob Res, 1 (1999), pp. 241-249
[8.]
Y. Hieda, D.E. Keyler, J.T. Vandervoort, J.K. Kane, C.A. Ross, D.E. Raphael, et al.
Active inmunization alters the plasma nicotine concentration in rats.
J Pharmacol Experimental Ther, 283 (1997), pp. 1076-1081
[9.]
Y. Hieda, D.E. Keyler, S. Ennifar, A. Fattom, P.R. Pentel.
Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain.
Int J Inmunopharmacol, 22 (2000), pp. 809-819
[10.]
P.R. Pentel, D.H. Malin, S. Ennifar, Y. Hieda, D.E. Keyler, J.R. Lake, et al.
A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats.
Pharmacol Biochem Behv, 65 (2000), pp. 191-198
[11.]
N. Lindblom, S.H.L. De Villiers, G. Kalayanov, S. Gordon, A.M. Johansson, T.H. Svensson.
Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats.
Respiration, 69 (2002), pp. 254-260
[12.]
S.H.L. De Villiers, N. Lindhom, G. Kalayanov, S. Gordon, A. Malmerfelt, A.M. Johansson, et al.
Active immunization against nicotine-induced dopamine release in the rats nucleus accumbens shell.
Respiration, 69 (2002), pp. 247-253
[13.]
D.H. Malin, J.R. Lake, A. Lin, M. Saldana, L. Balch, M.L. Irvin, et al.
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.
Pharmacol Biochem Behav, 68 (2001), pp. 87-92
[14.]
TA-NIC nicotine vaccine. Disponible en: www.xenova.co.uk/dc_ta_nic.html
[15.]
J.S. Clair Roberts, J. Dobson, D. Wood, M. Settles.
Safety and imnunogenicity of nicotine conjugate vaccine.
Proceedings of Annual Meeting of the College on Problems of Drug Dependence CPDD,
[16.]
J.S. Clair Roberts, C.V.R. Akers, L. Vanhinsbergh, K.A. McKenna, D.M. Wood, L. Jack, et al.
Longitudinal safety and inmunogenicity data of TA-NIC, a novel nicotine vaccine.
Proceedings of Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT),
[17.]
K. Lindmayer, G. Horwith, A. Fattom, R. Naso, S. Fuller, L. Muenz, et al.
Results of a phase 1, double blinded, controlled safety and inmunogenicity trial of NICVAX™, a conjugated nicotine vaccine.
Proceedings of IV European Conference of the Society for Research on Nicotine and Tobacco (SRNT),
[18.]
K. Lindmayer, G. Horwith, A. Fattom, R. Naso, S. Fuller, L. Muenz, et al.
Results of a phase 1, double blinded, controlled safety and inmunogenicity trial of NICVAXTM, a conjugated nicotine vaccine.
Proceedings of IV European Conference of the Society for Research on Nicotine and Tobacco (SRNT);,
[19.]
C.J. Bunce, P.T. Loudon, C. Akers, J. Dobson, D.M. Wood.
Development of vaccines to help treat drug dependence.
Curr Opin Mol Ther, 5 (2003), pp. 58-63
[20.]
S.D. Satoskar, D.E. Keyler, M.G. Le Sage, D.E. Raphael, C. Ross, P.R. Pentel.
Tissue dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats.
Int Immunopharmacol, 3 (2003), pp. 957-970
[21.]
P. Pentel, D. Malin.
A vaccine for nicotine dependence: targeting the drug rather than the brain.
Respiration, 69 (2002), pp. 193-197
[22.]
E.H. Cerny, R. Lévy, J. Mauel, M. Mpandi, M. Mutter, C. Henzelin-Nkubana, et al.
Preclinical development of a vaccine against smoking.
Onkologie, 25 (2002), pp. 406-411
[23.]
S.D. Sanderson, S.R. Cheruku, M.P. Padmanilayam, J.L. Vennerstrom, G.M. Thiele, M.I. Palmatier, et al.
Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant.
Int Immunopharmacol, 3 (2003), pp. 137-146
[24.]
M.R.A. Carrera, J.A. Ashley, T.Z. Hoffman, S. Isomura, P. Wirsching, G.F. Koob, et al.
Investigation using immunization to attenuate the psychoactive effects of nicotine.
Bioorg Med Chem, 12 (2004), pp. 563-570
[25.]
E.M. Sellers, H.L. Kaplan, R.F. Tyndale.
Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
Clin Pharmacol Ther, 68 (2000), pp. 35-43
[26.]
M.M. Meijler, M. Matsushita, L.J. Altobell, P. Wirsching, K.D. Janda.
A new strategy for improved nicotine vaccines using conformationally constrained haptens.
J Am Chem Soc, 125 (2003), pp. 7164-7165
[27.]
Respiratory Reviews.com. New approaches to smoking cessation show promise. Disponible en: http://www.respiratoryreviews.com/mar01/rr_cessation.html
[28.]
W. Hall.
The prospects for immunotherapy in smoking cessation.
Lancet, 360 (2002), pp. 1089-1091
[29.]
F.J. Vocci, C.N. Chiang.
Vaccines against nicotine: how effective are they likely to be in preventing smoking?.
CNS Drugs, 15 (2001), pp. 505-514
[30.]
D.E. Keyler, D. Shoeman, M.G. Lessge, A.D. Calvin, P.R. Pentel.
Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats.
J Pharmacol Exp Ther, 305 (2003), pp. 587-592
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?